Active targeting of manganese nanoparticles for MRI contrast enhancement: prospects and challenges

Authors:
Publisher website
Google Scholar
Abstract
The growing interest in Mn2+ ions for T1-weighted contrast agents (CAs) stems from their biogenic nature, driving the development of Mn-based complexes and nanoparticles. To enhance tumor contrast and minimize side effects from retention in healthy tissues, active targeting of Mn-based CAs is crucial. Key targeting strategies for Mn2+-based CAs are reviewed alongside those for Gd3+ and iron oxide agents, as Mn2+ CAs were developed later. In this review, the main focus is on Mn-containing nanoparticles, since from the point of view of the contrast effect and limited delivery of Mn2+ ions, they are a more promising basis for CA than molecular Mn2+ complexes. Hydrophilic nanoplatforms such as triblock copolymer micelles, silica nanoparticles and protein nanoparticles are the focus of this review due to their widespread use in the design of CAs and their ability to be easily conjugated with functional groups required for active targeting. The literature examples show that the T1-weighted contrast of such nanoplatforms conjugated with targeting molecules may differ from that of unconjugated ones, since the high lability of the surface exposed Mn2+ ions promotes their redistribution due to coordination through chelating groups on the conjugated nanoplatform. However, this aspect of the development of manganese-based nanoscale contrast agents has not been sufficiently discussed in previous reviews devoted to such nanomaterials. The bibliography includes 120 references.

This publication has 118 references indexed in Scilit: